# Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder

> **NCT00385437** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 16 (—)

## Conditions studied

- Depression
- Excessive Daytime Sleepiness

## Interventions

- **BEHAVIORAL:** Driving Simulator Testing
- **DRUG:** Mirtazapine Treatment

## Key facts

- **NCT ID:** NCT00385437
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2004-06
- **Target enrollment:** 16 (—)
- **Last updated:** 2006-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385437, "Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00385437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*